Activating the NF-κB pathway in microglia, can subsequently increase the amount of tau seeding and spreading and most AD patients are detected with considerably higher levels of NF-κB (Kaltschmidt et al., 1997). This evidence concerns the gene MAPT and Alzheimer disease.